High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers
Muhammad Baghdadi(Hokkaido University), Ken‐ichiro Seino(Hokkaido University), Nao Suzuki(St. Marianna University School of Medicine), Atsushi Takano(Shiga University of Medical Science), Hiroyuki Ito(Kanagawa Prefectural Hospital Organization), Yohei Miyagi(Kanagawa Cancer Center), Haruka Wada(Hokkaido University), Haruhiko Nakayama, Hiraku Endo(St. Marianna University School of Medicine), Y. Kameda(Hokkaido University), Yataro Daigo(The University of Tokyo), Kozo Ishikawa(Hokkaido University), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization)
Cited by 116
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593